Not Every Biopharma Team Needs Full Pharmacovigilance Outsourcing
In a recent industry discussion around partial pharmacovigilance outsourcing, one point stood out clearly: Not every biopharma company needs full pharmacovigilance outsourcing.And
SafeCue Industry Pulse 2026
Early Observations on ICSR Narrative Consistency and Inspection Defensibility ICSR narratives play a critical role in pharmacovigilance by providing the clinical context necessary
How to Handle Conflicting Source Documents (and Document It Correctly)
In pharmacovigilance, the source documents don’t always agree. A clinical narrative may conflict with a discharge summary. A lab report may contradict a progress note. An EDC ent
SafeCue Solutions Is Heading to the World Drug Safety Congress Americas 2025!
SafeCue Solutions is thrilled to announce that we’ll be exhibiting at the World Drug Safety Congress Americas, taking place November 4-6, 2025, in Boston, MA — one of the large
When Pharmacovigilance Is an Afterthought: The Hidden Risks to Clinical Trials and Patients
In drug development, every decision affects both the science and the people behind it. But when pharmacovigilance (PV) is treated as an afterthought—rushed, under-resourced, or t